MedPath

Pinotbio, Inc.

🇰🇷South Korea
Ownership
Holding
Employees
-
Market Cap
-
Website
http://www.pinotbio.com

Safety and Tolerability of NTX-101 in Korean Healthy Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
Drug: Placebo
First Posted Date
2021-09-13
Last Posted Date
2022-04-20
Lead Sponsor
Pinotbio, Inc.
Target Recruit Count
36
Registration Number
NCT05041543
Locations
🇰🇷

Inje University Busan Paik Hospital, Busan, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath